ArticleScientific reports2025
Network toxicology combined with molecular docking technology to explore the molecular mechanism of amatoxin causing liver injury.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Article
- Long-term enoxaparin use and osteoporosis risk: a real-world cohort study with integrative computational and network toxicology approaches.Journal of translational medicine · 2026Article
- Role of microRNA-136 inWorld journal of gastrointestinal oncology · 2026Article
- Integrating machine learning, deep learning, and docking to predict aristolochic acid A carcinogenesis.Frontiers in pharmacology · 2026Article
- The effect of phytoestrogens and PAHs on endometriosis and the involvement of gut microbiota, inflammation, and molecular targets.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
As one of the most toxic molecules in the fungal kingdom, amatoxin exhibit exceptional thermal stability and acid resistance. Once ingested, these compounds are rapidly absorbed and transported unimpeded to vital organs. They disrupt cellular metabolism by inhibiting nucleic acid and protein synthesis in target organs, ultimately causing hepatic and renal necrosis. Without prompt intervention, this molecular sabotage can progress to multiorgan failure and death. Early diagnosis combined with aggressive therapeutic measures is crucial for mitigating acute hepatic damage and significantly improving survival outcomes. This study aims to elucidate the molecular mechanisms underlying amatoxin-induced hepatic injury and establish a theoretical framework for targeted therapeutic interventions. Computational toxicology approaches utilizing ProTox-3.0 and ADMETlab 2.0 platforms were employed to characterize amatoxin's toxicological profile. Target prediction was performed through STITCH and SwissTargetPrediction databases, while liver injury-associated targets were identified from GeneCards, OMIM, and TTD repositories. The intersectional targets underwent systematic bioinformatics analysis, including protein-protein interaction (PPI) network construction, Gene Ontology (GO) annotation, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment. Molecular docking simulations were subsequently conducted to characterize three-dimensional binding conformations between amatoxin and core target proteins. Computational screening identified 11 potential amatoxin targets using STITCH and SwissTargetPrediction databases. Parallel interrogation of GeneCards, OMIM, and TTD repositories yielded 1,730 liver injury-related genes. Venn diagram analysis pinpointed SP1 and CNR1 as consensus molecular targets at the amatoxin-hepatic injury interface. PPI network topology revealed critical nodal connections, while functional enrichment analyses delineated key biological processes and signaling pathways associated with these targets. Molecular docking simulations demonstrated high-affinity binding between amatoxin and both SP1 and CNR1, suggesting direct mechanistic interactions. Amatoxin likely exerts hepatotoxic effects through direct binding to the core molecular targets SP1 and CNR1, thereby perturbing downstream transcriptional regulation and disrupting critical signaling cascades, ultimately culminating in hepatic necrosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.